MARC details
000 -LEADER |
fixed length control field |
02233nam a22004457a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
180928s20182018 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
1935-1089 |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1097/ICB.0000000000000499 [doi] |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
PMID |
27997458 |
245 ## - TITLE STATEMENT |
Title |
ACUTE RETINAL NECROSIS AFTER ADMINISTRATION OF ADALIMUMAB, A SYSTEMIC ANTITUMOR NECROSIS FACTOR ANTIBODY. |
251 ## - Source |
Source |
RETINAL Cases & Brief Reports. 12(4):307-309, 2018 Fall. |
252 ## - Abbreviated Source |
Abbreviated source |
Retin. cases brief rep.. 12(4):307-309, 2018 Fall. |
253 ## - Journal Name |
Journal name |
Retinal cases & brief reports |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Year |
2018 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Manufacturer |
FY2019 |
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
Publication status |
ppublish |
266 ## - Date added to catalog |
Date added to catalog |
2018-09-28 |
501 ## - WITH NOTE |
Local holdings |
Available online through MWHC library: 2007 - present |
520 ## - SUMMARY, ETC. |
Abstract |
CONCLUSION: Physicians prescribing tumor necrosis factor alpha antagonist immunosuppressive therapy should be aware of the potential of developing acute retinal necrosis. |
520 ## - SUMMARY, ETC. |
Abstract |
METHODS: Case report. |
520 ## - SUMMARY, ETC. |
Abstract |
PURPOSE: To report a case of acute retinal necrosis in a patient on anti-tumor necrosis factor alpha immunosuppressive therapy. |
520 ## - SUMMARY, ETC. |
Abstract |
RESULTS: A 47-year-old man with psoriasis presented with blurred vision and floaters in the left eye 4 days after receiving his fourth dose of adalimumab, a tumor necrosis factor alpha antagonist. He was diagnosed with acute retinal necrosis and was treated with intravenous acyclovir as well as prophylactic laser barricade. Seven years later, he is 20/20 with no history of a retinal detachment. |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Adalimumab/ae [Adverse Effects] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Anti-Inflammatory Agents/ae [Adverse Effects] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Retinal Necrosis Syndrome, Acute/ci [Chemically Induced] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Humans |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Male |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Middle Aged |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Tumor Necrosis Factor-alpha/ai [Antagonists & Inhibitors] |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
MedStar Union Memorial Hospital |
656 ## - INDEX TERM--OCCUPATION |
Department |
Medicine |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Case Reports |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Journal Article |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Campbell, Wayne |
790 ## - Authors |
All authors |
Campbell W, Garff K, Klima K, Schechet SA, Schocket LS |
856 ## - ELECTRONIC LOCATION AND ACCESS |
DOI |
<a href="https://dx.doi.org/10.1097/ICB.0000000000000499">https://dx.doi.org/10.1097/ICB.0000000000000499</a> |
Public note |
https://dx.doi.org/10.1097/ICB.0000000000000499 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Journal Article |
Item type description |
Article |